Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Influence of co-initiation of antiulcer drugs on persistence and adherence to low-dose aspirin: A retrospective cohort study using a Japanese claims database
.

Iwasawa M, Sagami K, Yokoyama S, Hosomi K, Takada M.

Int J Clin Pharmacol Ther. 2019 Dec 19. doi: 10.5414/CP203634. [Epub ahead of print]

PMID:
31854295
2.

Adherence to guidelines for antiulcer drug prescription in patients receiving low-dose aspirin therapy in Japan.

Iwasawa M, Sagami K, Yokoyama S, Hosomi K, Takada M.

Int J Clin Pharmacol Ther. 2019 Apr;57(4):197-206. doi: 10.5414/CP203370.

PMID:
30663979
3.

Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.

Soliman AM, Bonafede M, Farr AM, Castelli-Haley J, Winkel C.

J Manag Care Spec Pharm. 2016 May;22(5):573-87. doi: 10.18553/jmcp.2016.22.5.573.

4.

One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.

Chen SY, Wu N, Gulseth M, LaMori J, Bookhart BK, Boulanger L, Fields L, Schein J.

J Manag Care Pharm. 2013 May;19(4):291-301.

5.
6.

Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.

Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain RL, Swindle RW.

J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54.

7.

[Retrospective cohort study for the impact on readmission of patients with ischemic stroke after treatment of aspirin plus clopidogrel or aspirin mono-therapy].

Yang C, Zhang YQ, Tang X, Gao P, Wei CL, Hu YH.

Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Jun 18;48(3):442-7. Chinese.

8.

Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.

Spivey CA, Qiao Y, Liu X, Mardekian J, Parker RB, Phatak H, Claflin AB, Kachroo S, Abdulsattar Y, Chakrabarti A, Wang J.

J Manag Care Spec Pharm. 2015 Jul;21(7):596-606.

9.

Bleeding Risk of Warfarin and Direct Oral Anticoagulants in Younger Population: A Historical Cohort Study Using a Japanese Claims Database.

Yokoyama S, Tanaka Y, Nakagita K, Hosomi K, Takada M.

Int J Med Sci. 2018 Nov 22;15(14):1686-1693. doi: 10.7150/ijms.28877. eCollection 2018.

10.

Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.

Lapi F, Levi M, Simonetti M, Cancian M, Parretti D, Cricelli I, Sobrero A, Cricelli C.

Int J Cancer. 2016 Jul 1;139(1):205-11. doi: 10.1002/ijc.30061. Epub 2016 Mar 15.

11.

Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation.

Nelson WW, Song X, Thomson E, Smith DM, Coleman CI, Damaraju CV, Schein JR.

Curr Med Res Opin. 2015;31(10):1831-40. doi: 10.1185/03007995.2015.1074064. Epub 2015 Sep 4.

PMID:
26211816
12.

Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.

Hedberg J, Sundström J, Thuresson M, Aarskog P, Oldgren J, Bodegard J.

J Intern Med. 2013 Oct;274(4):371-80. doi: 10.1111/joim.12103. Epub 2013 Jul 10.

13.

Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.

Hirata Y, Kataoka H, Shimura T, Mizushima T, Mizoshita T, Tanida S, Kamiya T, Joh T.

Scand J Gastroenterol. 2011 Jul;46(7-8):803-9. doi: 10.3109/00365521.2011.568522. Epub 2011 Apr 19.

PMID:
21501103
14.

Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation.

Nelson WW, Song X, Coleman CI, Thomson E, Smith DM, Damaraju CV, Schein JR.

Curr Med Res Opin. 2014 Dec;30(12):2461-9. doi: 10.1185/03007995.2014.933577. Epub 2014 Jun 25.

PMID:
24926732
15.

Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.

Warlé-van Herwaarden MF, Koffeman AR, Valkhoff VE, 't Jong GW, Kramers C, Sturkenboom MC, De Smet PA.

Br J Clin Pharmacol. 2015 Sep;80(3):589-98. doi: 10.1111/bcp.12626. Epub 2015 May 22.

16.

Adherence and persistence among chronic myeloid leukemia patients during second-line tyrosine kinase inhibitor treatment.

Trivedi D, Landsman-Blumberg P, Darkow T, Smith D, McMorrow D, Mullins CD.

J Manag Care Spec Pharm. 2014 Oct;20(10):1006-15.

17.

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).

Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, Gordon C, Ruiz-Irastorza G, Egurbide MV, Gil A, Espinosa G, Houssiau F, Rahman A, Martin H, McHugh N, Galindo M, Akil M, Amigo MC, Murru V, Khamashta MA.

Rheumatology (Oxford). 2014 Feb;53(2):275-84. doi: 10.1093/rheumatology/ket313. Epub 2013 Oct 4.

PMID:
24097288
18.
19.

Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries.

Fujita T, Kutsumi H, Sanuki T, Hayakumo T, Azuma T.

J Gastroenterol. 2013 May;48(5):559-73. doi: 10.1007/s00535-013-0771-8. Epub 2013 Mar 5. Review.

20.

Supplemental Content

Support Center